Diagnostic imaging in gynecologic malignancy

Minerva Ginecologica

Volumn 60, Issue 2, 2008, Pages 143-154

  Bhosale, P ^a   Iyer, R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Diagnostic imaging; Endometrial neoplasms; Ovarian neoplasms; Uterine cervical neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

ADNEXA DISEASE; BLEEDING; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORPUS LUTEUM; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; ECHOGRAPHY; ENDOMETRIUM CANCER; ENDOMETRIUM TUMOR; FOLLOW UP; GYNECOLOGIC CANCER; IMAGE ANALYSIS; IMAGE ENHANCEMENT; METASTASIS; METRORRHAGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PELVIC DISEASE; PELVIS PAIN SYNDROME; POSITRON EMISSION TOMOGRAPHY; REVIEW; SAFETY; SENSITIVITY AND SPECIFICITY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TERATOMA; THREE DIMENSIONAL IMAGING;

CERVIX UTERI; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47249154335     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Togashi K, Morikawa K, Kataoka ML, Konishi J. Cervical cancer. J Magn Reson Imaging 1998;8:391-7.
3. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995;86:43-50.
4. Mayr NA, Tali ET, Yuh WT, Brown BP, Wen BC, Buller RE et al. Cervical cancer: application of MR imaging in radiation therapy. Radiology 1993;189:601-8.
5. Levenback C, Dershaw DD, Rubin SC. Endoluminal ultrasound staging of cervical cancer. Gynecol Oncol 1992;46:186-90.
6. Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005;23:9329-37.
7. Ascher SM, Takahama J, Jha RC. Staging of gynecologic malignancies. Top Magn Reson Imaging 2001;12:105-29.
8. Ozsarlak O, Tjalma W, Schepens E, Corthouts B, Op de Beeck B, Van Marck E et al. The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma. Eur Radiol 2003;13:2338-45.
9. Rockall AG, Ghosh S, Alexander-Sefre F, Babar S, Younis MT, Naz S et al. Can MRI rule out bladder and rectal invasion in cervical cancer to help select patients for limited EUA? Gynecol Oncol 2006;101:244-9.
10. Kim SH, Han MC. Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging. AJR Am J Roentgenol 1997;168:393-7.
11. Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54:759-67.
12. McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA. Diffusion-weighted MRI in cervical cancer. Eur Radiol 2008;18:1058-64.
13. Stehman FB, Bundy BN, DiSaia PJ, Keys HM, Larson JE, Fowler WC. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991;67:2776-85.
14. Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 1999;73:106-10.
15. Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 2005;97:183-91.
16. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA 1997;278:1096-101.
17. Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL. Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 1999;40:1125-31.
18. Sun SS, Chen TC, Yen RF, Shen YY, Changlai SP, Kao A. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Anticancer Res 2001;21:2957-61.
19. Sironi S, Picchio M, Landoni C, Galimberti S, Signorelli M, Bettinardi V et al. Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging 2007;34:472-9.
20. Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med 2003;44:347-52.
21. Belhocine TZ. 18F-FDG PET imaging in posttherapy monitoring of cervical cancers: from diagnosis to prognosis. J Nucl Med 2004;45:1602-4.
22. Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK et al. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 2004;95:546-51.
23. Institute NC. Endometrial cancer and Estrogen, Surveillance epidemiology and end results [Internet]. Bethesda, MD [cited 2008 March 17]. Available from: http://seer.cancer.gov/studies/surveillance/study3.html.
24. Benshushan A. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment. Eur J Obstet Gynecol Reprod Biol 2004;117:132-7.
25. Hanf V, Gunthert AR, Emons G. Endometrial cancer. Onkologie 2003;26:429-36.
26. Reinhold C, Khalili I. Postmenopausal bleeding: value of imaging. Radiol Clin North Am 2002;40:527-62.
27. Davis PC, O'Neill MJ, Yoder IC, Lee SI, Mueller PR. Sonohysterographic findings of endometrial and subendometrial conditions. Radiographics 2002;22:803-16.
28. Dubinsky TJ, Stroehlein K, Abu-Ghazzeh Y, Parvey HR, Maklad N. Prediction of benign and malignant endometrial disease: hysterosonographic-pathologic correlation. Radiology 1999;210:393-7.
29. Lehotska V, Svec J, Durkovsky A, Suhajdova A, Sevcikova L. Relevance of the Doppler flowmetry in the diagnosis of pathological alterations in the postmenopausal endometrium. Neoplasma 1999;46:253-6.
30. Yazbeck C, Poncelet C, Crequat J, Madelenat P. [Preoperative endovaginal ultrasound in the assessment of myometrial invasion of endometrial adenocarcinoma]. Gynecol Obstet Fertil 2003;31:1024-9.
31. Szantho A, Szabo I, Csapo ZS, Balega J, Demeter A, Papp Z. Assessment of myometrial and cervical invasion of endometrial cancer by transvaginal sonography. Eur J Gynaecol Oncol 2001;22:209-12.
32. Dessole S, Rubattu G, Farina M, Capobianco G, Cherchi PL, Tanda F et al. Risks and usefulness of sonohysterography in patients with endometrial carcinoma. Am J Obstet Gynecol 2006;194:362-8.
33. Hamlin DJ, Burgener FA, Beecham JB. CT of intramural endometrial carcinoma: contrast enhancement is essential. AJR Am J Roentgenol 1981;137:551-4.
34. Hawner J. Uterine and cervical tumors. Oxford: Isis Medical Media Ltd.; 1998.
35. Sironi S, Zanello A, Rodighiero MG, Vanzulli A, Taccagni GL, Belloni C et al. Invasive carcinoma of the cervix uteri (Stage IB-IIB). Comparison of CT and MR for the assessment of the parametrium. Radiol Med (Torino) 1991;81:671-7.
36. Hardesty LA, Sumkin JH, Hakim C, Johns C, Nath M. The ability of helical CT to preoperatively stage endometrial carcinoma. AJR Am J Roentgenol 2001;176:603-6.
37. Buy JN, Ghossain MA, Sciot C, Bazot M, Guinet C, Prevot S et al. Epithelial tumors of the ovary: CT findings and correlation with US. Radiology 1991;178:811-8.
38. Connor JP, Andrews JI, Anderson B, Buller RE. Computed tomography in endometrial carcinoma. Obstet Gynecol 2000;95:692-6.
39. Chen SS, Kumari S, Lee L. Contribution of abdominal computer tomography (CT) in the management of gynecologic cancer: correlated study of CT image and gross surgical pathology. Gynecol Oncol 1980;10:162-72.
40. Mann WJ, Baim R, Patsner B, Chalas E, Taylor A, Westermann C et al. The value of CT scanning in the management of patients with gynecologic malignancies. Arch Gynecol Obstet 1989;246:15-25.
41. Kerr-Wilson RH, Shingleton HM, Orr JW Jr., Hatch KD. The use of ultrasound and computed tomography scanning in the management of gynecologic cancer patients. Gynecol Oncol 1984;18:54-61.
42. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 1991;179:829-32.
43. Shen SH, Chiou YY, Wang JH, Yen MS, Lee RC, Lai CR et al. Diffusion-weighted single-shot echo-planar imaging with parallel technique in assessment of endometrial cancer. AJR Am J Roentgenol 2008;190:481-8.
44. Ortashi O, Jain S, Emannuel O, Henry R, Wood A, Evans J. Evaluation of the sensitivity, specificity, positive and negative predictive values of preoperative magnetic resonance imaging for staging endometrial cancer A prospective study of 100 cases at the Dorset Cancer Centre. Eur J Obstet Gynecol Reprod Biol 2008;137:232-5.
45. Kinsella TJ, Bloomer WD, Lavin PT, Knapp RC. Stage II endometrial carcinoma: 10-year follow-up of combined radiation and surgical treatment. Gynecol Oncol 1980;10:290-7.
46. Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825-32.
47. Chen SS, Lee L. Reappraisal of endocervical curettage in predicting cervical involvement by endometrial carcinoma. J Reprod Med 1986;31:50-2.
48. Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005;23:2813-21.
49. Kitajima K, Murakami K, Yamasaki E, Hagiwara S, Fukasawa I, Inaba N et al. Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer. Ann Nucl Med 2008;22:103-9.
50. Belhocine T, De Barsy C, Hustinx R, Willems-Foidart J. Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 2002;29:1132-9.
51. Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK et al. The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings. Eur J Nucl Med Mol Imaging 2008 [Epub ahead of print].
52. Bristow RE, Duska LR, Lambrou NC, Fishman EK, O'Neill MJ, Trimble EL et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 2000;89:1532-40.
53. Bristow RE. Surgical standards in the management of ovarian cancer. Curr Opin Oncol 2000;12:474-80.
54. Mironov S, Akin O, Pandit-Taskar N, Harm LE. Ovarian cancer. Radiol Clin North Am 2007;45:149-66.
55. Coakley FV. Staging ovarian cancer: role of imaging. Radiol Clin North Am 2002;40:609-36.
56. Brown DL, Doubilet PM, Miller FH, Frates MC, Laing FC, DiSalvo DN et al. Benign and malignant ovarian mass-es: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology 1998;208:103-10.
57. Jokubkiene L, Sladkevicius P, Valentin L. Does three-dimensional power Doppler ultrasound help in discrimination between benign and malignant ovarian masses? Ultrasound Obstet Gynecol 2007;29:215-25.
58. Khan O, Cosgrove DO, Fried AM, Savage PE. Ovarian carcinoma follow-up: US versus laparotomy. Radiology 1986;159:111-3.
59. Johnson RJ. Radiology in the management of ovarian cancer. Clin Radiol 1993;48:75-82.
60. Sohaid SRR, Husband J. Ovarian Cancer. Oxford, UK: Isis Medical Media Ltd.; 1998.
61. Tempany CM, Zou KH, Silverman SG, Brown DL, Kurtz AB, McNeil BJ. Staging of advanced ovarian cancer: comparison of imaging modalities report from the Radiological Diagnostic Oncology Group. Radiology 2000;215:761-7.
62. Pannu HK, Horton KM, Fishman EK. Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers. J Comput Assist Tomogr 2003;27:333-40.
63. Gemignani ML, Chi DS, Gurin CC, Curtin JP, Barakat RR. Splenectomy in recurrent epithelial ovarian cancer. Gynecol Oncol 1999;72:407-10.
64. Lee SS, Morgenstern L, Phillips EH, Hiatt JR, Margulies DR. Splenectomy for splenic metastases: a changing clinical spectrum. Am Surg 2000;66:837-40.
65. Rieber A, Nussle K, Stohr I, Grab D, Fenchel S, Kreienberg R et al. Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. AJR Am J Roentgenol 2001;177:123-9.
66. Hricak H, Chen M, Coakley FV, Kinkel K, Yu KK, Sica G et al. Complex adnexal masses: detection and characterization with MR imaging - multivariate analysis. Radiology 2000;214:39-46.
67. Yoshida Y, Kurokawa T, Kawahara K, Tsuchida T, Okazawa H, Fujibayashi Y et al. Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR Am J Roentgenol 2004;182:227-33.
68. Sheng XG, Zhang XL, Fu Z, Li HQ, Li QS, Ma ZF et al. Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma. Zhonghua Fu Chan Ke Za Zhi 2007;42:460-3.
69. Soussan M, Wartski M, Cherel P, Fourme E, Goupil A, Le Stanc E et al. Impact of FDG PET-CT imaging on the decision making in the biologic suspicion of ovarian carcinoma recurrence. Gynecol Oncol 2008;108:160-5.
70. Thrall MM, DeLoia JA, Gallion H, Avril N. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer. Gynecol Oncol 2007;105:17-22.
71. Bidzinski M, Radziszewski J, Panek G, Danska-Bidzinska A. Risk of lymph node metastases in patients with ovarian cancer. Ginekol Pol 2003;74:671-6.
72. Holloway BJ, Gore ME, A'Hern RP, Parsons C. The significance of paracardiac lymph node enlargement in ovarian cancer. Clin Radiol 1997;52:692-7.